Faeth Therapeutics (FTH) Earnings Analysis
Faeth Therapeutics (FTH) has no confirmed upcoming earnings date. Last quarter (2026-05-15) it missed with EPS -131.45 USD vs -0.62 USD est (-21101.6%). It has beaten estimates in 3/4 recent quarters (75%). Trailing P/E -0.19.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does FTH next report earnings?
No confirmed upcoming earnings date is currently scheduled for FTH. This page updates as the calendar is published.
FTH earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-15 | -131.45 USD | -0.62 USD | -21101.6% | Miss |
| 2026-03-30 | -3.74 USD | -4.81 USD | +22.2% | Beat |
| 2025-11-14 | -3.62 USD | -4.11 USD | +11.9% | Beat |
| 2024-11-14 | -5.8 USD | -6.2 USD | +6.5% | Beat |
Beat rate: 3/4 (75%) over reported quarters with consensus data.
FTH valuation and analyst view
| Trailing P/E | -0.19 |
|---|---|
| Trailing EPS | -142.43289 USD |
| Price / book | 0.19 |
| Dividend yield | 0.00% |
| Market cap | 0.04B |
| Analyst consensus | Buy (4 buy / 0 hold / 0 sell) |
| Avg price target | 55.67 USD |
Related research pages
Frequently asked questions
When is Faeth Therapeutics (FTH)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for FTH. This page updates as the calendar is published.
Did FTH beat earnings last quarter?
In its 2026-05-15 report, FTH posted EPS of -131.45 USD versus a -0.62 USD estimate — a miss of 21101.6%.
What is FTH's earnings track record?
Over the last 4 reported quarters with consensus data, FTH beat estimates 3 times (75%).
What is FTH's current P/E ratio and EPS?
FTH trades at a trailing P/E of -0.19 on trailing EPS of -142.43289072562337 USD.
What do analysts rate FTH?
Analyst consensus is "Buy" across 4 ratings (0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 55.67 USD.